Back to Agenda
NCA Showcase: Brexit Implications for the EU27 Network and Decentralised Activities
Session Chair(s)
Christa Wirthumer-Hoche, PHD
Retired, Austria
This session gives the floor to the National Competent Authorities (NCA) to discuss their local progress, burning topics, and stakeholder engagement regarding Brexit.
Speaker(s)
Christa Wirthumer-Hoche, PHD
Retired, Austria
Brexit Implications for the HMA Multi-Annual Work Programme
Hugo Hurts
Chair HMA Brexit Task Force; Executive Director, Medicines Evaluation Board (MEB), Netherlands
HMA Brexit Task Force
Laura Oliveira Santamaria, MPHARM
Head of RRAA Division, Human Medicines Department, AEMPS, Spain
Focus on MRP/DCP
Virginia Acha, PHD, MSC
Global Lead, Global Regulatory Policy, Merck & Co., Inc., United States
How is Industry Preparing?
Stan A van Belkum, MSC
Deputy Director, Medicines Evaluation Board, Netherlands
Strengthening and Optimisation of Regulatory Procedures
Have an account?